نتایج جستجو برای: hbv core antibody

تعداد نتایج: 390403  

2017
Elizabeth Wahome Caroline Ngetsa John Mwambi Huub C. Gelderblom Gloria Omosa Manyonyi Murugi Micheni Amin Hassan Matt A. Price Susan M. Graham Eduard J. Sanders

No data exist on hepatitis B virus (HBV) incidence among African men who have sex with men (MSM). We tested plasma samples archived between 2005 and 2014 for HBV core antibody or surface antigen seroconversion in a cohort of 312 initially human immunodeficiency virus (HIV)-1-negative MSM with no evidence of prior HBV infection. Hepatitis B virus incidence was 6.0/100 person-years (95% confidenc...

2007
Samir Dervisevic Samreen Ijaz Shahneila Chaudry Richard S. Tedder

In the United Kingdom, the National Screening Programme for identification of hepatitits B virus (HBV) infection in pregnant women uses HBV e antigen (HBeAg) and antibody to HBeAg (anti-HBe) as markers of infectivity to determine use of immunoglobulin for hepatitis B. Serum samples from 114 HBV-infected women were analyzed. Viral loads correlated with HBeAg/anti-HBe status and viral genotypes. ...

Journal: :iranian journal of immunology 0
zahra habibagahi department of internal medicine, rheumatology research center, shiraz university of medical sciences, shiraz, iran mohammad ali nazarinia department of internal medicine, rheumatology research center, shiraz university of medical sciences, shiraz, iran elham aflaki department of internal medicine, rheumatology research center, shiraz university of medical sciences, shiraz, iran akbar rajaee department of internal medicine, rheumatology research center, shiraz university of medical sciences, shiraz, iran

background: the clinical significance of antiphospholipid antibodies in patients with chronic hepatitis c virus (hcv) and some other viral infections is controversial. objective: to study the prevalence of anticardiolipin antibody (acla) and antibeta2glycoproteini antibody (antibeta2gpi antibody) in hcv and hepatitis b virus (hbv) infected patients and its association with liver clinical parame...

Journal: :Actas dermo-sifiliograficas 2015
J Sanz-Bueno F Vanaclocha I García-Doval R Torrado G Carretero E Daudén D Patricia Ruiz-Genao M M Alsina-Gibert B Pérez-Zafrilla G Pérez-Rial R Rivera

INTRODUCTION AND OBJECTIVES A 5% risk of reactivation of hepatitis B virus (HBV) infection has been reported in patients with diseases other than psoriasis treated with tumor necrosis factor inhibitors. The aim of this study was to investigate the risk of HBV reactivation in patients with a past history of HBV infection who were receiving biologic therapy for psoriasis. MATERIAL AND METHODS T...

خلیلیان , علیرضا , صفار , هانا , صفار, محمدجعفر , گری نورانی, گلناز ,

Background and purpose: The aim of the present study was to identify the true extent of non-responsiveness in children vaccinated against Hepatitis B virus (HBV) ten years ago at birth whom were serologically susceptible to HBV,and had poor antibody response to booster HBV vaccine. Materials and Methods: Twenty low-and non-responding 11.5 years old children recuited in by another study rec...

Journal: :The Journal of infectious diseases 2009
Alexander Walz Stefan Wirth Jürgen Hucke Patrick Gerner

BACKGROUND Hepatitis B virus (HBV) can be transmitted by blood donors and organ donors who are positive for antibody to HBV core antigen (anti-HBc) but negative for all other HBV markers. Therefore, we evaluated the risk of infection for babies of mothers with this serostatus. METHODS A total of 2365 HBV surface antigen (HBsAg)-negative pregnant women were included in the study and screened f...

2015
Tatsuo Kanda Shuang Wu Reina Sasaki Masato Nakamura Yuki Haga Xia Jiang Shingo Nakamoto Osamu Yokosuka

Hepatitis B virus (HBV) infection, a cause of hepatocellular carcinoma (HCC), remains a serious global health concern. HCC development and human hepatocarcinogenesis are associated with hepatic inflammation caused by host interferons and cytokines. This article focused on the association between the HBV core protein, which is one of the HBV-encoding proteins, and cytokine production. The HBV co...

2013
N. TSUCHIYA P. PATHIPVANICH A. ROJANAWIWAT N. WICHUKCHINDA I. KOGA M. KOGA W. AUWANIT P. E. KILGORE K. ARIYOSHI P. SAWANPANYALERT

A total of 755 highly active antiretroviral therapy (HAART)-naive HIV-infected patients were enrolled at a government hospital in Thailand from 1 June 2000 to 15 October 2002. Census dateo f survival was on 31 October 2004 or the date of HAART initiation. Of 700 (92.6%) patients with complete data, the prevalence of hepatitis B virus (HBV) surface antigen and anti-hepatitis C virus (HCV) antibo...

2017
Yu-Lan Chen Ying-Qian Mo Dong-Hui Zheng Jian-Da Ma Jun Jing Lie Dai

Hepatitis B virus (HBV) reactivation is a well-recognized complication in patients who undergo immunosuppressive drug therapy. Although the recommendation of antiviral prophylaxis made by the American Gastroenterological Association in 2015 focuses on the risk stratification of different immunosuppressive drugs, risk factors for HBV reactivation are also worth identifying in clinical practice. ...

Journal: :Annals of oncology : official journal of the European Society for Medical Oncology 2012
D H T Mya S T Han Y C Linn W Y K Hwang Y T Goh D C L Tan

BACKGROUND The purpose of the study is to analyse the prevalence of hepatitis B virus (HBV) infection and its incidence of reactivation among multiple myeloma (MM) patients treated in the era of novel therapy in an endemic Asian setting. PATIENTS AND METHODS From 2000 to 2008, 273 patients with newly diagnosed MM were screened for the presence of hepatitis B virus surface antigen and HBV core...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید